Tumor-bearing NOG mice were treated with human L1CAM-SS-28/ζ CAR T cells, whose murine counterpart performed best in our SK-N-BE(2) mouse model and compared anti-cancer efficacy to L1CAM-SS-4-1BB/ζ CAR T cells. Here, L1CAM is linked to neoplasm.